QTL mapping for traits associated with stress neuroendocrine reactivity in rats.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 16151695)

Published in Mamm Genome on July 01, 2005

Authors

Bastien Llamas1, Vincent Contesse, Véronique Guyonnet-Duperat, Hubert Vaudry, Pierre Mormède, Marie-Pierre Moisan

Author Affiliations

1: Laboratoire Neurogénétique et Stress, INSERM U471/INRA UMR1243, Université Victor Segalen Bordeaux 2, Institut François Magendie, Rue Camille Saint Saens, 33077 Bordeaux cedex, France.

Articles cited by this

Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics (1989) 79.44

A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity (Edinb) (1992) 55.23

Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet (1995) 49.77

Empirical threshold values for quantitative trait mapping. Genetics (1994) 46.95

Genetic dissection of complex traits. Science (1994) 29.54

Finding genes that underlie complex traits. Science (2002) 7.39

Map Manager QTX, cross-platform software for genetic mapping. Mamm Genome (2001) 6.60

Confidence intervals in QTL mapping by bootstrapping. Genetics (1996) 5.99

Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet (2001) 3.70

From QTL to gene: the harvest begins. Nat Genet (2002) 2.79

A simple method to calculate resolving power and confidence interval of QTL map location. Behav Genet (1997) 2.37

The evolution of the stress concept. Am Sci (1973) 1.67

Differential expression of AT1 receptors in the pituitary and adrenal gland of SHR and WKY. Hypertension (2003) 1.61

Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol Psychol (2001) 1.56

Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension (1994) 1.38

Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation. Biochem Biophys Res Commun (1992) 1.31

The role of aquaporins in dendritic cell macropinocytosis. J Exp Med (2000) 1.24

Plasma membrane aquaporin activity can affect the rate of apoptosis but is inhibited after apoptotic volume decrease. Am J Physiol Cell Physiol (2003) 1.16

Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. Neuroendocrinology (1996) 1.13

A major quantitative trait locus influences hyperactivity in the WKHA rat. Nat Genet (1996) 1.11

Peripheral administration of an angiotensin II AT(1) receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation Stress. Endocrinology (2001) 1.08

Identification of female-specific QTLs affecting an emotionality-related behavior in rats. Mol Psychiatry (1999) 1.08

X-linked and lineage-dependent inheritance of coping responses to stress. Mamm Genome (2003) 1.06

Comparison of the behavioural and endocrine response to forced swimming stress in five inbred strains of rats. Psychoneuroendocrinology (1995) 1.02

A quantitative trait locus influencing anxiety in the laboratory rat. Genome Res (2002) 0.99

Familial pattern of corticosteroids and their metabolism in adult human subjects--the Scottish Adult Twin Study. J Clin Endocrinol Metab (1999) 0.98

Restraint stress modulates brain, pituitary and adrenal expression of angiotensin II AT(1A), AT(1B) and AT(2) receptors. Neuroendocrinology (2002) 0.97

Two new inbred rat strains derived from SHR: WKHA, hyperactive, and WKHT, hypertensive, rats. Am J Physiol (1991) 0.96

Distribution of angiotensin type-1 receptor messenger RNA expression in the adult rat brain. Neuroscience (1998) 0.94

Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Mol Pharmacol (1991) 0.92

Independent genetic susceptibility to cardiac hypertrophy in inherited hypertension. Hypertension (1998) 0.92

Aquaporins: a water channel family. Anat Sci Int (2002) 0.89

Molecular genetic approaches to investigate individual variations in behavioral and neuroendocrine stress responses. Psychoneuroendocrinology (2002) 0.89

Aldosterone enhances renin gene expression in juxtaglomerular cells. Am J Physiol Renal Physiol (2003) 0.88

The molecular neurobiology of stress--evidence from genetic and epigenetic models. Behav Pharmacol (2001) 0.84

Behavioral and neuroendocrine reactivity to stress in the WKHA/WKY inbred rat strains: a multifactorial and genetic analysis. Brain Res (1996) 0.84

Activation of 5-HT(7) receptor in rat glomerulosa cells is associated with an increase in adenylyl cyclase activity and calcium influx through T-type calcium channels. Endocrinology (2002) 0.84

Hypothalamic-pituitary-adrenal axis activity in the inbred Brown Norway and Fischer 344 rat strains. Life Sci (1998) 0.83

Regulation of aquaporin mRNA expression in rat kidney by water intake. J Am Soc Nephrol (1999) 0.82

Further dissection of a genomic locus associated with behavioral activity in the Wistar-Kyoto hyperactive rat, an animal model of hyperkinesis. Mol Psychiatry (2003) 0.82

Strain differences in corticosteroid receptor efficiencies and regulation in Brown Norway and Fischer 344 rats. J Neuroendocrinol (1999) 0.81

Comparison of the neuroendocrine responses to stress in outbred, inbred and F1 hybrid rats. Life Sci (1998) 0.81

Contribution of autosomal loci and the Y chromosome to the stress response in rats. Hypertension (2000) 0.81

Pharmacological evidence that the sympathetic nervous system mediates the increase in renin secretion produced by immobilization and head-up tilt in rats. Neuropharmacology (1988) 0.80

Exaggerated response to restraint stress in rats congenic for the chromosome 1 blood pressure quantitative trait locus. Clin Exp Pharmacol Physiol (2003) 0.80

Opposite feedback control of renin and aldosterone biosynthesis in the adrenal cortex by angiotensin II AT1-subtype receptors. Hypertension (1997) 0.79

Genomic regions controlling corticosterone levels in rats. Biol Psychiatry (2004) 0.79

Angiotensin I-converting enzyme genotype influences arterial response to injury in normotensive rats. Arterioscler Thromb Vasc Biol (1998) 0.79

Genetic influences on plasma catecholamines in human twins. J Clin Endocrinol Metab (1993) 0.78

Strain differences in sympathetic-adrenal medullary responsiveness and behavior. Behav Neural Biol (1984) 0.77

Plasma aldosterone and corticosterone responses to adrenocorticotropin, angiotensin, potassium, and stress in spontaneously hypertensive rats. Endocrinology (1981) 0.77

Gain of function mutation in the mineralocorticoid receptor of the Brown Norway rat. J Biol Chem (2004) 0.77

A comparison of acute stress paradigms: hormonal responses and hypothalamic serotonin. Physiol Behav (1987) 0.77

Psychoneuroendocrine profile associated with hypertension or hyperactivity in spontaneously hypertensive rats. Am J Physiol (1993) 0.76

On the mechanism of renin release by restraint stress in rats. Pharmacol Biochem Behav (1978) 0.76

Direct radioimmunoassay for plasma corticosterone and aldosterone in frog. I. Validation of the methods and evidence for daily rhythms in a natural environment. Gen Comp Endocrinol (1982) 0.76

Is the mineralocorticoid receptor in Brown Norway rats constitutively active? J Neuroendocrinol (2000) 0.75

Articles by these authors

Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev (2009) 3.22

Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol (2012) 1.64

Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci U S A (2004) 1.58

Anaerobic sulfatase-maturating enzymes: radical SAM enzymes able to catalyze in vitro sulfatase post-translational modification. J Am Chem Soc (2007) 1.32

Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Front Neuroendocrinol (2009) 1.26

A cAMP-dependent, protein kinase A-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells. Mol Pharmacol (2008) 1.24

Molecular evolution of multiple forms of kisspeptins and GPR54 receptors in vertebrates. Endocrinology (2009) 1.20

Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity. Proc Natl Acad Sci U S A (2003) 1.19

The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways. J Neurochem (2006) 1.14

Organization of two independent kisspeptin systems derived from evolutionary-ancient kiss genes in the brain of zebrafish. Endocrinology (2011) 1.10

Neurotrophic effects of PACAP in the cerebellar cortex. Peptides (2007) 1.07

Intracellular signaling pathways activated by kisspeptins through GPR54: do multiple signals underlie function diversity? Peptides (2008) 1.07

Anaerobic sulfatase-maturating enzymes, first dual substrate radical S-adenosylmethionine enzymes. J Biol Chem (2008) 1.06

Anaerobic sulfatase-maturating enzyme--a mechanistic link with glycyl radical-activating enzymes? FEBS J (2010) 1.06

Mechanistic investigations of anaerobic sulfatase-maturating enzyme: direct Cbeta H-atom abstraction catalyzed by a radical AdoMet enzyme. J Am Chem Soc (2009) 1.06

Abnormal sensitivity of cortisol-producing adrenocortical adenomas to serotonin: in vivo and in vitro studies. J Clin Endocrinol Metab (2005) 1.05

Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands. Gen Comp Endocrinol (2006) 1.03

In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab (2004) 1.03

Role of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum. Mol Immunol (2008) 1.02

Plasma transcortin influences endocrine and behavioral stress responses in mice. Endocrinology (2009) 1.02

PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells. Eur J Neurosci (2003) 1.01

Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion. FASEB J (2008) 1.01

Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. J Mol Neurosci (2008) 1.01

Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent Inhibition of sirtuin 1. J Biol Chem (2011) 1.00

Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy. J Clin Endocrinol Metab (2007) 1.00

VIP and PACAP induce selective neuronal differentiation of mouse embryonic stem cells. Eur J Neurosci (2004) 0.99

Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor. J Med Chem (2009) 0.99

Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation. Neuroprotective effect of C5a against apoptotic cell death. J Biol Chem (2004) 0.98

Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. Curr Pharm Des (2011) 0.96

Role of PACAP in the physiology and pathology of the sympathoadrenal system. Front Neuroendocrinol (2007) 0.96

Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Proc Natl Acad Sci U S A (2002) 0.96

Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Neuropsychopharmacology (2008) 0.96

Revisiting the evolution of gonadotropin-releasing hormones and their receptors in vertebrates: secrets hidden in genomes. Gen Comp Endocrinol (2010) 0.96

The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation. Biochem J (2010) 0.95

Gene array and real time PCR analysis of the adrenal sensitivity to adrenocorticotropic hormone in pig. BMC Genomics (2008) 0.94

Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity. J Cereb Blood Flow Metab (2008) 0.94

Aryldithioethyloxycarbonyl (Ardec): a new family of amine protecting groups removable under mild reducing conditions and their applications to peptide synthesis. Chemistry (2006) 0.93

Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake. Neuropsychopharmacology (2006) 0.93

An indispensable role of secretin in mediating the osmoregulatory functions of angiotensin II. FASEB J (2010) 0.93

Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli. J Am Soc Nephrol (2008) 0.93

In vivo and in vitro structure-activity relationships and structural conformation of Kisspeptin-10-related peptides. Mol Pharmacol (2009) 0.93

Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and alpha-melanocyte-stimulating hormone breakdown in the rat brain. J Neurochem (2003) 0.93

Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas. Eur J Endocrinol (2005) 0.92

Corticosteroid binding globulin gene polymorphism influences cortisol driven fat distribution in obese women. Obes Res (2005) 0.92

Conditioned taste aversion and alcohol drinking: strain and gender differences. J Stud Alcohol (2002) 0.92

Localization of the urotensin II receptor in the rat central nervous system. J Comp Neurol (2006) 0.92

Cycloheximide treatment to identify components of the transitional transcriptome in PACAP-induced PC12 cell differentiation. J Neurochem (2006) 0.92

Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion. Endocrinology (2003) 0.92

Molecular genetics of hypothalamic-pituitary-adrenal axis activity and function. Ann N Y Acad Sci (2011) 0.92

Interleukin-1beta and anaphylatoxins exert a synergistic effect on NGF expression by astrocytes. J Neuroinflammation (2006) 0.91

Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J Neurochem (2004) 0.91

Novel stable PACAP analogs with potent activity towards the PAC1 receptor. Peptides (2008) 0.91

Molecular coevolution of kisspeptins and their receptors from fish to mammals. Ann N Y Acad Sci (2010) 0.91

Central effects of native urotensin II on motor activity, ventilatory movements, and heart rate in the trout Oncorhynchus mykiss. Brain Res (2004) 0.90

Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells. J Neurosci Res (2003) 0.90

Tumor necrosis factor (TNF)-alpha persistently activates nuclear factor-kappaB signaling through the type 2 TNF receptor in chromaffin cells: implications for long-term regulation of neuropeptide gene expression in inflammation. Endocrinology (2008) 0.90

Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the rat. J Comp Neurol (2007) 0.90

Structure-activity relationships and structural conformation of a novel urotensin II-related peptide. Peptides (2004) 0.90

Corticosteroid binding globulin: a new target for cortisol-driven obesity. Mol Endocrinol (2004) 0.90

Isolation, characterization, and distribution of a novel neuropeptide, Rana RFamide (R-RFa), in the brain of the European green frog Rana esculenta. J Comp Neurol (2002) 0.90

Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae). Toxicon (2008) 0.90

Behavioral effects of 26RFamide and related peptides. Peptides (2006) 0.90

Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab (2006) 0.90

PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action. Peptides (2011) 0.89

The proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1 stimulate neuropeptide gene transcription and secretion in adrenochromaffin cells via activation of extracellularly regulated kinase 1/2 and p38 protein kinases, and activator protein-1 transcription factors. Mol Endocrinol (2004) 0.89

Identification, localization, and function of a novel avian hypothalamic neuropeptide, 26RFa, and its cognate receptor, G protein-coupled receptor-103. Endocrinology (2010) 0.89

Identification of amino acid residues that direct differential ligand selectivity of mammalian and nonmammalian V1a type receptors for arginine vasopressin and vasotocin. Insights into molecular coevolution of V1a type receptors and their ligands. J Biol Chem (2004) 0.88

Critical role of plasma corticosteroid-binding-globulin during stress to promote glucocorticoid delivery to the brain: impact on memory retrieval. Endocrinology (2012) 0.88

Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies. J Clin Endocrinol Metab (2006) 0.87

Localization of the mRNA encoding prolyl endopeptidase in the rat brain and pituitary. J Comp Neurol (2004) 0.87

Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab (2003) 0.87

Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects. Biochem Pharmacol (2010) 0.87

Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis. J Neurochem (2011) 0.87

The RFamide neuropeptide 26RFa and its role in the control of neuroendocrine functions. Front Neuroendocrinol (2011) 0.87

Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide. Biochim Biophys Acta (2012) 0.87

Discovery of growth hormone-releasing hormones and receptors in nonmammalian vertebrates. Proc Natl Acad Sci U S A (2007) 0.87

Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide. J Control Release (2012) 0.87

Expansion of secretin-like G protein-coupled receptors and their peptide ligands via local duplications before and after two rounds of whole-genome duplication. Mol Biol Evol (2013) 0.87

Cellular uptake of ODNs in HIV-1 human-infected cells: a role for viral particles in DNA delivery? Oligonucleotides (2007) 0.87

Genetics of behaviour: phenotypic and molecular study of rats derived from high- and low-alcohol consuming lines. Pharmacogenetics (2003) 0.87

Comparative distribution of the mRNAs encoding urotensin I and urotensin II in zebrafish. Peptides (2008) 0.87

PAC1 receptor activation by PACAP-38 mediates Ca2+ release from a cAMP-dependent pool in human fetal adrenal gland chromaffin cells. J Biol Chem (2002) 0.86

Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes. J Neurochem (2006) 0.86

Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling. Proc Natl Acad Sci U S A (2005) 0.86

Gliotransmission and brain glucose sensing: critical role of endozepines. Diabetes (2012) 0.86

Long-term alterations in vulnerability to addiction to drugs of abuse and in brain gene expression after early life ethanol exposure. Neuropharmacology (2008) 0.86

Genetic influences on behavioral and neuroendocrine responses to predator-odor stress in rats. Neurosci Lett (2006) 0.86

New insight into the molecular evolution of the somatostatin family. Mol Cell Endocrinol (2008) 0.86

Bradykinin-related peptides and tryptophyllins in the skin secretions of the most primitive extant frog, Ascaphus truei. Gen Comp Endocrinol (2005) 0.86

Expression of melanocortin MC3 and MC4 receptor mRNAs by neuropeptide Y neurons in the rat arcuate nucleus. Neuroendocrinology (2006) 0.85

Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction. J Neurochem (2008) 0.85

Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats. Eur J Neurosci (2002) 0.85

Molecular Coevolution of Neuropeptides Gonadotropin-Releasing Hormone and Kisspeptin with their Cognate G Protein-Coupled Receptors. Front Neurosci (2012) 0.85

Prolactin increases the synthesis of 7alpha-hydroxypregnenolone, a key factor for induction of locomotor activity, in breeding male Newts. Endocrinology (2010) 0.85